Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33370 | 93 | 36.7 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BIKDD | Author keyword | 6 | 80% | 4% | 4 |
| 2 | MITOCHONDRIAL CYTOCHROME C RELEASE | Author keyword | 1 | 40% | 2% | 2 |
| 3 | BAX OVEREXPRESSION | Author keyword | 1 | 50% | 1% | 1 |
| 4 | ORAL MAXILLO IAL SURG REPARAT REGE | Address | 1 | 50% | 1% | 1 |
| 5 | TBAX | Author keyword | 1 | 50% | 1% | 1 |
| 6 | TOPOISOMERASE II ALPHA PROMOTER | Author keyword | 1 | 50% | 1% | 1 |
| 7 | WALLACE TUMOR 620 | Address | 1 | 50% | 1% | 1 |
| 8 | ESOPHAGEAL CARCINOMA CELL | Author keyword | 0 | 33% | 1% | 1 |
| 9 | FAM83D | Author keyword | 0 | 33% | 1% | 1 |
| 10 | MOL BIOTHER Y TOSHIMA KU | Address | 0 | 18% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BIKDD | 6 | 80% | 4% | 4 | Search BIKDD | Search BIKDD |
| 2 | MITOCHONDRIAL CYTOCHROME C RELEASE | 1 | 40% | 2% | 2 | Search MITOCHONDRIAL+CYTOCHROME+C+RELEASE | Search MITOCHONDRIAL+CYTOCHROME+C+RELEASE |
| 3 | BAX OVEREXPRESSION | 1 | 50% | 1% | 1 | Search BAX+OVEREXPRESSION | Search BAX+OVEREXPRESSION |
| 4 | TBAX | 1 | 50% | 1% | 1 | Search TBAX | Search TBAX |
| 5 | TOPOISOMERASE II ALPHA PROMOTER | 1 | 50% | 1% | 1 | Search TOPOISOMERASE+II+ALPHA+PROMOTER | Search TOPOISOMERASE+II+ALPHA+PROMOTER |
| 6 | ESOPHAGEAL CARCINOMA CELL | 0 | 33% | 1% | 1 | Search ESOPHAGEAL+CARCINOMA+CELL | Search ESOPHAGEAL+CARCINOMA+CELL |
| 7 | FAM83D | 0 | 33% | 1% | 1 | Search FAM83D | Search FAM83D |
| 8 | FAM83B | 0 | 25% | 1% | 1 | Search FAM83B | Search FAM83B |
| 9 | P1 MODEL | 0 | 25% | 1% | 1 | Search P1+MODEL | Search P1+MODEL |
| 10 | BAYESIAN STATISTICAL MODELING | 0 | 20% | 1% | 1 | Search BAYESIAN+STATISTICAL+MODELING | Search BAYESIAN+STATISTICAL+MODELING |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NONINVASIVE IMAGING MODELS | 6 | 80% | 4% | 4 |
| 2 | ELIMINATES BREAST CANCER | 3 | 100% | 3% | 3 |
| 3 | AR EXPRESSION | 1 | 50% | 1% | 1 |
| 4 | TARGETING IMPROVES | 1 | 50% | 1% | 1 |
| 5 | PROAPOPTOTIC GENE BAX | 1 | 18% | 3% | 3 |
| 6 | CASPASE 7 | 0 | 18% | 2% | 2 |
| 7 | NUTLIN 3 | 0 | 10% | 3% | 3 |
| 8 | BIK NBK | 0 | 25% | 1% | 1 |
| 9 | LEUKOPROTEASE INHIBITOR GENE | 0 | 25% | 1% | 1 |
| 10 | RECOMBINANT GELONIN | 0 | 25% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Signaling cross-talk in the resistance to HER family receptor targeted therapy | 2014 | 14 | 134 | 4% |
| Tumor-suppressing gene therapy | 2003 | 25 | 91 | 4% |
| 3rd Geneva aging workshop 2002: cancer, apoptosis and aging | 2003 | 0 | 31 | 6% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ORAL MAXILLO IAL SURG REPARAT REGE | 1 | 50% | 1.1% | 1 |
| 2 | WALLACE TUMOR 620 | 1 | 50% | 1.1% | 1 |
| 3 | MOL BIOTHER Y TOSHIMA KU | 0 | 18% | 2.2% | 2 |
| 4 | INTRACTABLE IMMUNE DIS | 0 | 25% | 1.1% | 1 |
| 5 | UNIT 79 | 0 | 25% | 1.1% | 1 |
| 6 | GRCP | 0 | 20% | 1.1% | 1 |
| 7 | UNIT 079 | 0 | 20% | 1.1% | 1 |
| 8 | OPTOSIS PROGRAM | 0 | 17% | 1.1% | 1 |
| 9 | HAIKOU PEOPLES HOSP | 0 | 13% | 1.1% | 1 |
| 10 | LIVING DONOR LIVER TRANSPLANTATMINIST PU | 0 | 13% | 1.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000172343 | BCL 2//BCL 2 PROTEIN//BCL X |
| 2 | 0.0000141861 | CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE |
| 3 | 0.0000114737 | MCL 1//ABT 737//BCL 2 FAMILY |
| 4 | 0.0000103662 | MRNA DELIVERY//MRNA TRANSFECTION//RIBOL |
| 5 | 0.0000081708 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
| 6 | 0.0000069947 | L1210 CELL LINE//TCRP1//MOL PHYSIOL GENET |
| 7 | 0.0000067912 | APAF 1//CASPASE 2//RAIDD |
| 8 | 0.0000061576 | PDCD5//PROGRAMMED CELL DEATH 5//PROGRAMMED CELL DEATH 5 PDCD5 |
| 9 | 0.0000060426 | ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS |
| 10 | 0.0000060230 | TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND |